- Home
- BWB vs ITOS Comparison
BWB vs ITOS Comparison
Compare BWB & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWB
- ITOS
- Stock Information
- Founded
- BWB 2005
- ITOS 2011
- Country
- BWB United States
- ITOS United States
- Employees
- BWB N/A
- ITOS N/A
- Industry
- BWB Major Banks
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BWB Finance
- ITOS Health Care
- Exchange
- BWB Nasdaq
- ITOS Nasdaq
- Market Cap
- BWB 442.3M
- ITOS 450.9M
- IPO Year
- BWB 2018
- ITOS 2020
- Fundamental
- Price
- BWB $16.50
- ITOS $10.19
- Analyst Decision
- BWB Strong Buy
- ITOS Hold
- Analyst Count
- BWB 2
- ITOS 6
- Target Price
- BWB $20.00
- ITOS $10.40
- AVG Volume (30 Days)
- BWB 56.7K
- ITOS 1.0M
- Earning Date
- BWB 07-23-2025
- ITOS 08-06-2025
- Dividend Yield
- BWB N/A
- ITOS N/A
- EPS Growth
- BWB 12.01
- ITOS N/A
- EPS
- BWB 1.21
- ITOS N/A
- Revenue
- BWB $119,312,000.00
- ITOS N/A
- Revenue This Year
- BWB $32.24
- ITOS N/A
- Revenue Next Year
- BWB $11.45
- ITOS N/A
- P/E Ratio
- BWB $13.63
- ITOS N/A
- Revenue Growth
- BWB 12.23
- ITOS 177.89
- 52 Week Low
- BWB $11.93
- ITOS $4.80
- 52 Week High
- BWB $17.66
- ITOS $18.01
- Technical
- Relative Strength Index (RSI)
- BWB 61.61
- ITOS 60.66
- Support Level
- BWB $15.43
- ITOS $10.10
- Resistance Level
- BWB $16.07
- ITOS $10.22
- Average True Range (ATR)
- BWB 0.42
- ITOS 0.04
- MACD
- BWB 0.06
- ITOS -0.00
- Stochastic Oscillator
- BWB 98.16
- ITOS 78.57
About BWB Bridgewater Bancshares Inc.
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering them a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.